I'm going to run with pure naivety here and a little blind faith in our new board and management. DT has stated the market will be updated if and when they are in possession of material facts that will prohibit RAC from dosing a patient this year. In @HeyLine s post he says they have no option but to inform shareholders if and when this is the case. Are we assuming they know they won't dose this year but aren't telling us or are we just suggesting the likelihood is low but nothing material has eventuated to fully discount the possibility.
RAC Price at posting:
$1.59 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)